BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37199468)

  • 1. The continuing discovery on the evidence for RNA editing in SARS-CoV-2.
    Pu X; Xu Q; Wang J; Liu B
    RNA Biol; 2023 Jan; 20(1):219-222. PubMed ID: 37199468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence Supporting That C-to-U RNA Editing Is the Major Force That Drives SARS-CoV-2 Evolution.
    Wang J; Wu L; Pu X; Liu B; Cao M
    J Mol Evol; 2023 Apr; 91(2):214-224. PubMed ID: 36799984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.
    Ratcliff J; Simmonds P
    Virology; 2021 Apr; 556():62-72. PubMed ID: 33545556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.
    Simmonds P
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospect of the Two-Year Debate: What Fuels the Evolution of SARS-CoV-2: RNA Editing or Replication Error?
    Wei L
    Curr Microbiol; 2023 Mar; 80(5):151. PubMed ID: 36976379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.
    Kim K; Calabrese P; Wang S; Qin C; Rao Y; Feng P; Chen XS
    Sci Rep; 2022 Sep; 12(1):14972. PubMed ID: 36100631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-to-U RNA deamination is the driving force accelerating SARS-CoV-2 evolution.
    Li Y; Hou F; Zhou M; Yang X; Yin B; Jiang W; Xu H
    Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36347544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.
    Vlachogiannis NI; Verrou KM; Stellos K; Sfikakis PP; Paraskevis D
    Clin Immunol; 2021 May; 226():108699. PubMed ID: 33639276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The substitution spectra of coronavirus genomes.
    Forni D; Cagliani R; Pontremoli C; Clerici M; Sironi M
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34518866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution.
    Song Y; He X; Yang W; Wu Y; Cui J; Tang T; Zhang R
    Nucleic Acids Res; 2022 Mar; 50(5):2509-2521. PubMed ID: 35234938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA.
    Simmonds P; Ansari MA
    PLoS Pathog; 2021 Jun; 17(6):e1009596. PubMed ID: 34061905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2.
    Ringlander J; Fingal J; Kann H; Prakash K; Rydell G; Andersson M; Martner A; Lindh M; Horal P; Hellstrand K; Kann M
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35064076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.
    Kosuge M; Furusawa-Nishii E; Ito K; Saito Y; Ogasawara K
    Sci Rep; 2020 Oct; 10(1):17766. PubMed ID: 33082451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rampant C-to-U deamination accounts for the intrinsically high mutation rate in SARS-CoV-2 spike gene.
    Liu X; Liu X; Zhou J; Dong Y; Jiang W; Jiang W
    RNA; 2022 Jul; 28(7):917-926. PubMed ID: 35508354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells.
    Peng X; Luo Y; Li H; Guo X; Chen H; Ji X; Liang H
    PLoS Genet; 2022 Mar; 18(3):e1010130. PubMed ID: 35353808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host Immune Response Driving SARS-CoV-2 Evolution.
    Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on "Poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2".
    Martignano F; Di Giorgio S; Mattiuz G; Conticello SG
    J Appl Genet; 2022 May; 63(2):423-428. PubMed ID: 35279801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From RNA World to SARS-CoV-2: The Edited Story of RNA Viral Evolution.
    Kockler ZW; Gordenin DA
    Cells; 2021 Jun; 10(6):. PubMed ID: 34202997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.
    Kim K; Calabrese P; Wang S; Qin C; Rao Y; Feng P; Chen XS
    bioRxiv; 2022 Apr; ():. PubMed ID: 34981048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.